A b s t r a c t
Thymoma is the most common neoplasm derived from epithelial cells of thymus. 1 Its heterogeneous oncologic behavior, histologic variability, and association with myasthenia gravis (MG) have been well established. 2 The histologic classification of thymoma had been one of the most controversial in tumor classification until an agreement on the universal classification system for thymic epithelial tumors was achieved by the World Health Organization (WHO) in 1999, which was further modified in 2004. 3, 4 According to the new classification system, thymoma is divided into 5 subtypes, including A, AB, B1, B2, and B3, and histologic behavior ranges from benignancy to low-or moderate-grade malignance. It is well accepted that the WHO histologic classification is a reliable prognostic indicator. [5] [6] [7] Metaplastic thymoma is a rare histologic variant and is characterized by a histologic biphasic growth pattern. 3, 8 Given the rarity of the cases, the few previous reports have focused only on morphologic and ultrastructural aspects of the tumor. [9] [10] [11] [12] The etiologic factors, clinical and pathologic features, and genetic aberrations of metaplastic thymoma have not been well described. Although most previously reported cases had a benign clinical course, metaplastic thymomas were also reported to be biologically heterogeneous with local recurrence and malignant transformation. [13] [14] [15] We report 7 cases of metaplastic thymoma and describe the clinicopathologic, immunophenotypic, and genetic features of these tumors.
Materials and Methods

Patients and Tumor Specimens
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Nanjing, China, were retrospectively examined for all cases pathologically diagnosed as thymic epithelial tumor. Seven cases of metaplastic thymoma were identified, with slides, tissue blocks, and fresh-frozen tissue (cases 4 and 5) available for this study. Morphologic classification was conducted according to the WHO classification of thymic epithelial tumors published in 2004. 3 Clinical stage was assessed based on the criteria proposed by Masaoka et al. 16 The institutional review boards of both participating institutions granted approval of the protocol for this study.
Immunohistochemical Analysis
Formalin-fixed, paraffin-embedded tissues were cut to 4-μm-thick sections. Immunohistochemical staining was undertaken using the EnVision kit (DakoCytomation, Copenhagen, Denmark). The primary antibodies used for immunostaining and antigen retrieval methods are listed in ❚Table 1❚. All incubations were kept at room temperature. The color was displayed with diaminobenzidine and counterstained with hematoxylin. Positive and negative controls were included on tissues known to contain each of the antigens. For the negative controls, phosphate-buffered saline was used in the absence of primary antibodies, confirming the specificity of each primary antibody.
DNA Extraction and Comparative Genomic Hybridization
DNA extraction was performed using a well-established protocol. 17 Briefly, in each case of paraffin-embedded tissue blocks, 20 serial, 10-μm-thick sections were cut. The first and last cuts were stained with H&E to ensure high tumor content, which was used as guidance for the following dissection. Fresh frozen tissue materials from 2 cases (cases 4 and 5) were available. Tumor tissue was digested with Proteinase K. DNA was extracted using phenol-chloroform, followed by ethanol precipitation. Reference DNA was obtained from the lymphocytes of a healthy donor. When sufficient DNA was available, comparative genomic hybridization (CGH) analysis was performed according to a standard protocol. 18 Briefly, 1 μg of DNA from tumor and normal reference were labeled with SpectrumGreen-deoxyuridine triphosphate (dUTP) and SpectrumRed-dUTP (Vysis, Downers Grove, IL), respectively, by nick translation at 15°C for 2 hours. After labeling, 200 ng of each probe was mixed, denatured, and hybridized to denatured normal metaphase chromosomes at 37°C for 2 days. The image of hybridized metaphases was captured and analyzed using the Quips CGH program (Vysis) and interpreted according to the fluorescence intensity profile according to the program instruction. The threshold values of gain and loss for DNA copy number were defined as an intensity ratio of tumor/normal of more than 1.2 and less than 0.8, respectively. High copy number amplification was defined as the intensity ratio of tumor/normal of more than 1.5.
Epstein-Barr Virus-Encoded RNA In Situ Hybridization
Formalin-fixed and paraffin-embedded tissues cut to 4-μm-thick sections on slides coated with poly-L-lysine were routinely deparaffinized, dehydrated, and predigested with 0.1 mg/mL of Proteinase K. Sections were incubated with 20 μL of fluorescein isothiocyanate (FITC)-labeled oligonucleotide probe (code No. Y017, DAKO, Carpinteria, CA) at 37°C for 2 hours. Then 25 μL of alkaline phosphatase-conjugated rabbit anti-FITC antisera (code No. K046, DAKO) was added, and sections were incubated for 60 minutes. The sections were colorized with 100 μL of BCIP/NBT (5-bromo-4-chloro-3-indolylphosphate/4-nitroblue tetrazolium chloride; code No. K046, DAKO) in a dark room for 20 minutes. Counterstaining was done with 0.3% hematoxylin. The detection of Epstein-Barr virus (EBV)-encoded RNA (EBER) was shown as dark brown to black in the nuclei of the cells. An EBER+ nasopharyngeal carcinoma specimen was used as a positive control. A 1-mol/L concentration of tris(hydroxymethyl) aminomethane-buffered saline was used without the EBER probe as the negative control.
Results
Clinical Findings
Clinical data were obtained from patient records and are listed in ❚Table 2❚. The ages ranged from 36 to 61 years (median, 49.4 years). The female/male ratio was 5:2. Three patients complained of chest pain (cases 1, 6, and 7). One patient had dyspnea and cough (case 2). Three patients were asymptomatic, with a mediastinal mass being randomly identified by chest radiology (cases 3-5). Computed tomographic images are shown in ❚Image 1❚. None of the patients had signs or symptoms of MG or other autoimmune disorders. All tumors were Masaoka stage I thymoma and were totally resected. No adjuvant chemotherapy or radiotherapy was given after the surgical operation. All patients survived in follow-up ranging from 11 to 172 months (mean, 81.7 months).
Gross and Microscopic Findings
Grossly, the tumors were solitary and well-encapsulated ovoid masses with the maximum dimensions averaging 8.0 cm (range, 5.0-14.0 cm). Cut surfaces were homogeneous, rubbery, and gray to white without evident necrosis. Microscopically, all tumors were characterized by a biphasic pattern composed of epithelial components and spindle cells ❚Image 2A❚. The epithelial areas consisted of anastomosing cords and islands or broad trabeculae of cohesive neoplasia cells ❚Image 2B❚. In cases 1 and 4, focal epithelial areas exhibited whorled squamoid configuration or abortive formation of Hassall corpuscles ❚Image 2C❚. The epithelial cells were polygonal, ovoid, or round, with oval nuclei and fairly abundant eosinophilic cytoplasm ❚Image 2D❚. Some epithelial cells showed the presence of prominent nuclear grooves or nuclear pseudoinclusions (Image 2C, inset, and Image 2D, inset). In some areas, the epithelial cells displayed overt cytologic atypia with large vesicular nuclei, large hyperchromatic nuclei, and multinucleation, yet mitotic activity was very low. The spindle cell components had a short fascicular or storiform growth pattern ❚Image 3A❚. The cells were bland appearing with a fine nuclear chromatin pattern, and mitoses were not found. Components with sharp delineation or gradual transition between them were displayed in all tumors ❚Image 3B❚. In the stroma, scattered small lymphocytes and plasma cells could be found. Two cases (cases 4 and 6) showed foci of coagulative necrosis with collections of foamy histiocytes ❚Image 5A❚. Both tumors were completely encapsulated, and the histomorphologic features, including cytologic atypia, mitotic activity, and Ki-67 index, were similar to those of the other 5 cases.
Immunohistochemical Findings
The results of immunohistochemical studies in all cases are summarized in ❚Table 3❚. The epithelial cells were diffusely and strongly positive for AE1/AE3 and E-cadherin in all tumors ❚Image 4A❚ and ❚Image 4B❚. These cells were focally and weakly positive for epithelial membrane antigen in 3 cases (cases 2, 3, and 7). The spindle cells were diffusely and strongly positive for vimentin and focally and weakly positive for AE1/AE3 and epithelial membrane antigen but negative for E-cadherin ❚Image 4C❚ and ❚Image 4D❚. Both tumor components in all tumors were negative for CD5, CD57, HMBE1, S-100, CD99, CD34, thyroid transcription factor-1, calretinin, Wilms tumor-1, epidermal growth factor receptor (EGFR), c-KIT, c-erbB-2, and p53. The Ki-67 fraction was low (<5%) in both components ❚Image 4E❚. The scanty stromal small lymphocytes and plasma cells displayed a mature immunophenotype positive for CD3, CD5, and CD20 and negative for terminal deoxynucleotidyl transferase, CD1a, and CD99.
Genetic Alterations
Sufficient DNA was extracted from 4 tumors (cases 2-4 and 6). No gross chromosomal abnormalities could be detected in any of the cases ❚Image 5B❚. Owing to a very low amount of stromal lymphocytes (<1.0%) in the tumor, the potential signals generated by contaminating nonneoplastic host cells were not a concern.
EBV Infection
The EBER signal was not detected in the epithelial components or spindle cells of any of the 7 cases. In immunohistochemical analysis, LMP-1 was not expressed in neoplastic cells in any of the cases.
Discussion
We retrospectively studied 7 cases of metaplastic thymoma. The rare variant of thymic tumor was morphologically characterized by a biphasic pattern comprising solid epithelial 
EGFR, epidermal growth factor receptor; EMA, epithelial membrane antigen; LMP1, latent membrane protein 1; NC, not counted; TdT, terminal deoxynucleotidyl transferase; TTF-1, thyroid transcription factor-1; WT-1, Wilms tumor-1; -, negative; ±, focally weak positive; +, diffusely positive; 2+, diffusely strong positive. metaplastic carcinoma," and "biphasic thymoma, mixed polygonal and spindle cell type." [8] [9] [10] [11] The discrepancies in terminology indicate that the biologic behavior of the tumor is confusing and controversial.
In our study, all 7 cases had some contradictory clinicopathologic properties. On the one hand, we observed tumor circumscription and encapsulation, bland-looking cytologic features, a low Ki-67 index, no gross genetic aberrations, and benign clinical course. These observations implied that metaplastic thymoma was a benign tumor. On the other hand, we found a lack of association with MG, tumor lobulation and perivascular spaces, inability to harbor immature lymphocytes, foci of neoplastic necrosis (cases 4 and 6), and the loss of E-cadherin expression in spindle cell components. These observations suggested that the tumor had properties of thymic malignancy.
The majority of metaplastic thymomas previously reported showed a benign clinic course; however, Yoneda and colleagues 10 described a patient in whom local recurrence developed at 14 months and who died within 6 years. Recently, Moritani et al 14 and Lu et al 15 conducted case studies on sarcomatoid carcinoma mimicking spindle cell sarcoma arising from metaplastic thymoma. Such reports implied that metaplastic thymoma could undergo malignant transformation since both epithelial and spindle cell components are considered neoplastic entities.
With regard to spindle cells, we are in agreement with the view of Yoneda and coworkers 10 that the spindle cell component is considered mesenchymal metaplasia of tumor cells. This metaplastic phenomenon is also known as epithelial-mesenchymal transition (EMT). 19 EMT is an essential developmental process by which cells of epithelial origin components intertwining with bundles of bland-looking spindle cells. Owing to its rarity and its peculiar histomorphologic and heterogeneous biologic features, metaplastic thymoma has been reported in the literature under designations such as "thymoma with pseudosarcomatoid stroma," "low-grade Ki-67 WT-1 LMP1 E-Cadherin c-erbB-2 EGFR CD117 p53 (%)
❚Image 5❚ (Case 6) Comparative genomic hybridization (CGH) finding of metaplastic thymoma. A, The tumor shows focal neoplastic necrosis mixed with foamy histiocytes. B, However, no gross chromosomal abnormalities were detected using CGH analysis.
c-KIT protein has been reported in thymic carcinoma and thymoma. 30 However, the abnormal expression of EGFR, c-KIT, c-erbB-2, and p53 was not detected in epithelial cells and spindle components in any of the 7 cases of metaplastic thymoma. The uniformly negative immunohistochemical stains for these markers suggest that EGFR, c-KIT, c-erbB-2, and p53 are not involved in the pathogenesis or progression of metaplastic thymoma. The etiology and molecular mechanisms of metaplastic thymoma merit further elucidation. Despite typical morphologic features, metaplastic thymoma should be distinguished from highly malignant and typically benign spindle cell neoplasms of the thymus. Thymic carcinosarcoma or sarcomatoid carcinoma always manifests with a high-grade spindle cell component that shows significant atypia, readily identified mitotic figures and prominent coagulative necrosis, and aggressive clinical behavior. Owing to the low-grade appearance of its spindle cell component, metaplastic thymoma can easily be distinguished from thymic carcinosarcoma and sarcomatoid carcinoma. The other differential diagnosis is type A and/or AB thymoma, and the distinction could be difficult if the spindle cell component predominates in metaplastic thymoma. However, some of the features such as lack of association with MG, tumor lobulation and perivascular spaces, inability to harbor immature lymphocytes, and loss of E-cadherin expression in spindle cell components could aid in the diagnosis of metaplastic thymoma.
Our study suggests that metaplastic thymomas are a rare but distinct group of tumors stemming from thymic epithelial cell. The elongated spindle cells probably undergo the EMT process, which is characterized by the loss of E-cadherin expression. EBV seems not to have an etiologic role in metaplastic thymoma. Metaplastic thymoma is more likely a benign tumor based on our molecular analysis and the relatively long survival in the cases studied. Unless the histomorphologic picture shows malignant features, surgical excision alone is recommended. lose epithelial characteristics and polarity and acquire mesenchymal (spindle) morphologic features with cytoskeletal reorganization. The transdifferentiated spindle components always display the loss of cytokeratin and E-cadherin expression and up-regulated expression of mesenchymal markers (vimentin). 20 An interesting finding of the present study is that the spindle cell components lose expression of E-cadherin, yet, the epithelial cells are diffusely and homogeneously positive for this molecule. Since the loss of E-cadherin is a defining characteristic of EMT, our finding supports the previous hypotheses that the elongated spindle cell components in metaplastic thymoma undergo a metaplastic process. 10, 21 Several previous studies showed rare expression of E-cadherin in spindle-shaped, medullary-type tumor epithelial cells in medullary (type A) and mixed-type (type AB) thymoma, whereas the epithelioid tumor cells in the majority of cortical thymomas (types B1 and B2) and in all cases of well-differentiated thymic carcinoma (B3 thymoma) showed diffuse E-cadherin expression. [22] [23] [24] These results indicate that E-cadherin expression has a more important role in the morphologic regulation of thymomas than in their biologic behavior because types A and AB thymoma are generally regarded as clinically benign tumors. Although in many malignant lesions, such as breast carcinoma, non-small cell lung carcinoma, and malignant pleural mesothelioma, [25] [26] [27] EMT or loss of E-cadherin expression is associated with increased aggressiveness and enhanced invasive and metastatic potential, our results suggest that this is not the case for metaplastic thymoma. In other words, a metaplastic process might not have an important role in malignant transformation of metaplastic thymoma.
The tumorigenesis of metaplastic thymoma remains unknown. All cases in our study were negative for EBV, suggesting that EBV infection is not etiologically involved in metaplastic thymoma. No evident genetic abnormalities were detected using CGH analysis in 4 tumors (cases 2-4 and 6), excluding the most common amplifications on chromosome 1q and loss of heterozygosity on chromosome 6 previously identified in types A and B3 thymoma and thymic carcinoma. [28] [29] [30] We further sought to determine whether individual genes, such as EGFR, c-erbB-2, c-KIT, and p53, are involved in the pathogenesis of metaplastic thymoma. The altered expression of these genes correlates with the development of many human malignancies, such as lung adenocarcinoma, colorectal cancer, breast carcinoma, gastrointestinal stromal tumor, and liver carcinoma. [31] [32] [33] The EGFR protein is frequently overexpressed in thymoma and thymic carcinoma, even though the striking discrepancy between protein overexpression and amplification and mutation of the EGFR gene has been reported. [34] [35] [36] [37] Likewise, c-KIT mutations were rare and found exclusively in thymic carcinomas, yet overexpression of the
